Showing 361-370 of 2072 results for "".
Spontaneous Intracranial Hemorrhage Secondary to Rare Pial Arteriovenous Fistula Rupture
https://practicalneurology.com/diseases-diagnoses/stroke/spontaneous-intracranial-hemorrhage-secondary-to-rare-pial-arteriovenous-fistula-rupture/35445/Pial arteriovenous fistulas are rare cerebrovascular malformations most commonly seen in children; however, they can be found in adults, especially in the setting of an intracranial hemorrhage.Direct Neural Invasion: A Proposed Mechanism for Neurologic Symptoms Associated with Chronic Lymphocytic Leukemia with No Mass Lesions
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/direct-neural-invasion-a-proposed-mechanism-for-neurologic-symptoms-associated-with-chronic-lymphocytic-leukemia-with-no-mass-lesions/35813/A high index of suspicion is required in patients with chronic lymphocytic leukemia presenting with otherwise unexplained neurologic symptoms, even in the absence of classic imaging findings.Hometown Highlights: Procedural Treatments for Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/hometown-highlights-procedural-treatments-formovement-disorders/31526/The Philadelphia Neurologic Society explores the journey from thalamotomy to MR-guided focused ultrasound for movement disorders.Sleep Spotlight: Who Needs to Ask About Sleep?
https://practicalneurology.com/diseases-diagnoses/sleep/sleep-spotlight-who-needs-to-ask-about-sleep/31938/A new survey study shows there is a gap in clinical conversations about sleep.Navigating Therapy: Exploring FDA-Approved Treatments for Effective AAD Care
https://practicalneurology.com/programs/cme/navigating-therapy-exploring-fda-approved-treatments-for-effective-aad-care/27101/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Innovative Therapeutics: How Pathophysiology Guides New AAD Treatment Development
https://practicalneurology.com/programs/cme/innovative-therapeutics-how-pathophysiology-guides-new-aad-treatment-development/27100/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Mapping the Mind: The Pathophysiology That Drives AAD
https://practicalneurology.com/programs/cme/mapping-the-mind-the-pathophysiology-that-drives-aad/27098/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
https://practicalneurology.com/programs/cme/patient-centric-innovations-in-ms-care-high-efficacy-dmts-cognition-and-special-patient-populations/29172/Learn more about the use of high-efficacy DMTs in multiple sclerosis.Optimizing Outcomes in AAD in Community PCP and LTC Clinics
https://practicalneurology.com/programs/cme/optimizing-outcomes-in-aad-in-community-pcp-and-ltc-clinics/26712/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Building Better Strategies: Incorporating New AAD Treatments Into Clinical Practice
https://practicalneurology.com/programs/cme/building-better-strategies-incorporating-new-aad-treatments-into-clinical-practice/27102/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.